Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,345 INR | -0.82% | +0.81% | -0.83% |
Apr. 16 | Caplin Point Arm Gets US FDA Final Nod for Ofloxacin Ophthalmic Solution | MT |
Mar. 28 | Caplin Point Unit Receives US FDA Nod for Eye Treatment Medication | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.83% | 1.23B | |
+21.00% | 43.18B | |
+20.46% | 22.59B | |
+15.11% | 14.56B | |
+42.34% | 11.5B | |
-8.64% | 6.93B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+10.21% | 5.36B | |
-2.27% | 4.81B |
- Stock Market
- Equities
- CAPLIPOINT Stock
- News Caplin Point Laboratories Limited
- Caplin Point Unit Receives US FDA Nod for Eye Treatment Medication